The SPAC in its latest filing said the $138 million raaise includes a $5 million PIPE.
Frazier’s sponsor is committed to purchasing another $25 million in a private placement at the time of any acquisition.
The biotech SPAC trades on the Nasdaq under FLACU. Read more.
